A cost-effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial)

East, C. E., Gascoigne, M. B., Doran, C. M., Brennecke, S. P., King, J. F. and Colditz, P. B. (2006) A cost-effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG: An International Journal of Obstetrics & Gynaecology, 113 9: 1080-1087.


Author East, C. E.
Gascoigne, M. B.
Doran, C. M.
Brennecke, S. P.
King, J. F.
Colditz, P. B.
Title A cost-effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial)
Journal name BJOG: An International Journal of Obstetrics & Gynaecology  (ERA 2012 Listed)    (ERA 2010 Rank A)   Check publisher's open access policy
Publication date 2006-09
Sub-type Article
DOI 10.1111/j.1471-0528.2006.01044.x
Volume number 113
Issue number 9
ISSN 1470-0328
Start page 1080
End page 1087
Total pages 8
Editor J. G. Thornton
Place of publication Oxford
Publisher Blackwell Publishing
Collection year 2006
Language eng
Subject C1
730217 Health status (e.g. indicators of well-being)
111402 Obstetrics and Gynaecology
Formatted abstract Objective To report an economic analysis of the Australian intrapartum fetal pulse oximetry (FPO) multicentre randomised controlled trial (the FOREMOST trial), which examined whether adding FPO to conventional cardiotocographic (CTG) monitoring (intervention group) was cost-effective in reducing operative delivery rates for non-reassuring fetal status compared with the use of CTG alone (control group).

Design Cost-effectiveness analysis of the FOREMOST trial.

Setting Four Australian maternity hospitals, each with more than 4000 births/year.

Population Women in labour at ≥36 weeks of gestation, with a non-reassuring CTG.

Methods Costs were for treatment-related expenses, incorporating diagnosis-related grouping costs and direct costs (including fetal monitoring). Incremental cost-effectiveness ratio (ICER) and cost-effectiveness plane were calculated, and sensitivity analysis was conducted. The primary outcome was that of the clinical trial: operative delivery for non-reassuring fetal status avoided in the intervention group relative to that in the control group.

Main outcome measures The ICER.

Results The ICER demonstrated a saving of $A813 for each operative birth for non-reassuring fetal status averted by the addition of FPO to CTG monitoring compared with the use of CTG monitoring alone.

Conclusion The addition of FPO to CTG monitoring represented a less costly and more effective use of resources to reduce operative delivery rates for non-reassuring fetal status than the use of conventional CTG monitoring alone.
Keyword Obstetrics & Gynecology
Economic Analysis
Fetal Pulse Oximetry
Randomised Controlled Trial
Alternative Modes
Labor
Pregnancy
Induction
Delivery
Q-Index Code C1

 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 3 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 5 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Access Statistics: 66 Abstract Views  -  Detailed Statistics
Created: Wed, 15 Aug 2007, 08:06:57 EST